Tumor necrosis factor-α increases lactoferrin transcytosis through the blood-brain barrier

Journal of Neurochemistry

Volumn 73, Issue 6, 1999, Pages 2491-2500

  Fillebeen, Carine ^a   Dehouck, Bénédicte ^b   Benaïssa, Monique ^a   Dhennin Duthille, Isabelle ^a   Cecchelli, Roméo ^b,c   Pierce, Annick ^a  

^a UNIV LILLE   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c UNIVERSITÉ D'ARTOIS   (France)

Author keywords

Blood brain barrier; Inflammation; Lactoferrin; Neurodegenerative disorders; Transendothelial transport; Tumor necrosis factor

Indexed keywords

LACTOFERRIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DEGENERATIVE DISEASE; GLIA CELL; HOST RESISTANCE; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; RECEPTOR UPREGULATION; TRANSCYTOSIS;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CATTLE; COCULTURE TECHNIQUES; E-SELECTIN; ENDOTHELIUM, VASCULAR; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LACTOFERRIN; RATS; STIMULATION, CHEMICAL; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BOVINAE;

EID: 0032733977     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0732491.x     Document Type: Article

References (58)

1. Appelmelk B. J., An Y. Q., Geerts M., Thijs B. G., de Boer H. A., MacLaren D. M., de Graaff J., and Nuijens J. H. (1994) Lactoferrin is a lipid A-binding protein. Infect. Immun. 62, 2628-2632.
2. Banks W. A., Kastin A. J., and Broadwell R. D. (1995) Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2, 241-248.
3. Baveye S., Elass E., Mazurier J., Spik G., and Legrand D. (1999) Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process. Clin. Chem. Lab. Med. 37, 281-286.
4. Bennett R. M. and Mohla C. (1976) A solid-phase radioimmunoassay for the measurement of lactoferrin in human plasma: variations with age, sex, and disease. J. Lab. Clin. Med. 88, 156-166.
5. Boxer L. A., Coates T. D., Haak R. A., Wolach J. B., Hoffstein S., and Baehner R. L. (1982) Lactoferrin deficiency associated with altered granulocyte function. N. Engl. J. Med. 307, 404-410.
6. Brayton J., Qing Z., Hart M. N., VanGilder J. C., and Fabry Z. (1998) Influence of adhesion molecule expression by human brain microvessel endothelium on cancer cell adhesion. J. Neuroimmunol. 89, 104-112.
7. Britigan B. E., Serody J. S., and Cohen M. S. (1994) The role of lactoferrin as an anti-inflammatory molecule. Adv. Exp. Med. Biol. 357, 143-156.
8. Chéron A., Mazurier J., and Fournet B. (1977) Chromatographic fractionation and studies on microheterogeneity of cow lactotransferrin prepared by an original procedure. C. R. Acad. Sci. Hebd. Seances Acad. Sci. D 284, 585-588.
9. Crouch S. P., Slater K. J., and Fletcher J. (1992) Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 80, 235-240.
10. Defazio G., Trojano M., Ribatti D., Nico B., Giorelli M., De Salvia R., Russo G., Roncali L., and Livrea P. (1998) ICAM-1 expression and fluid phase endocytosis of cultured brain microvascular endothelial cells following exposure to interferon β1a and TNF-α. J. Neuroimmunol. 88, 13-20.
11. Dehouck B., Fenart L., Dehouck M.-P., Pierce A., Torpier G., and Cecchelli R. (1997) A new function for the LDL receptor: transcytosis of LDL across the BBB. J. Cell Biol. 138, 877-889.
12. Dehouck M.-P., Méresse S., Delorme P., Torpier G., Fruchart J. C., and Cecchelli R. (1990) The blood-brain barrier in vitro: coculture of brain capillary endothelial cells and astrocytes. Circ. Metab. Cerveau 7, 151-162.
13. Deitch E. A. (1992) Multi organ failure: pathophysiology and potential future therapy. Ann. Surg. 216, 117-134.
14. Deli M. A., Descamps L., Dehouck M.-P., Cecchelli R., Joo F., Abraham C. S., and Torpier G. (1995) Exposure of tumor necrosis factor-α to luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin. J. Neurosci. Res. 41, 717-726.
15. Descamps L., Dehouck M.-P., Torpier G., and Cecchelli R. (1996) Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. Am. J. Physiol. 270, 1149-1158.
16. Descamps L., Cecchelli R., and Torpier G. (1997) Effects of tumor necrosis factor on receptor-mediated endocytosis and barrier functions of bovine brain capillary endothelial cell monolayers. J. Neuroimmunol. 74, 173-184.
17. Elass-Rochard E., Roseanu A., Legrand D., Trif M., Salmon V., Motas C., Montreuil J., and Spik G. (1995) Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide. Biochem. J. 312, 839-845.
18. Faucheux B., Nillesse N., Damier P., Spik G., Mouatt-Pringent A., Pierce A., Leveugle B., Kubis N., Hauw J.-J., Agid Y., and Hirsch E. (1995) Expression of lactotransferrin receptors is increased in the mesencephalon of patients with Parkinson's disease. Proc. Natl. Acad. Sci. USA 92, 9603-9607.
19. Fillebeen C., Dexter D., Mitchell V., Benaïssa M., Beauvillain J.-C, Spik G., and Pierce A. (1998) Lactoferrin is synthesized by mouse brain tissue and its expression is increased after MPTP treatment. Adv. Exp. Med. Biol. 443, 296-300.
20. Fillebeen C., Descamps L., Dehouck M.-P., Fenart L., Benaïssa M., Spik G., Cecchelli R., and Pierce A. (1999) Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J. Biol. Chem. 274, 7011-7017.
21. Fillit H., Ding W., Buée L., Kalman J., Altsiel L., Lawlor B., and Wolf-Klein G. (1991) Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci. Lett. 129, 318-320.
22. Goavec M., Mazurier J., Montreuil J., and Spik G. (1985) Role of glycans in the binding of human serotransferrin and lactotransferrin to human alveolar macrophages. C. R. Acad. Sci. III 301, 689-694.
23. Griffin W. S., Sheng J. G., Royston M. C., Gentleman S. M., McKenzie J. E., Graham D. I., Roberts G. W., and Mrak R. E. (1998) Glialneuronal interactions in Alzheimer's disease: the potential role of a cytokine cycle in disease progression. Brain Pathol. 8, 65-72.
24. Hull M., Strauss S., Berger M., Volk B., and Bauer J. (1996) Inflammatory mechanisms in Alzheimer's disease. Eur. Arch. Psychiatry Clin. Neurosci. 246, 124-128.
25. Kalaria R. N. and Hedera P. (1995) Differential degeneration of the cerebral microvasculature in Alzheimer's disease. Neuroreport 6, 477-480.
26. Kawamata T., Tooyama I., Yamada T., Walker D. G., and McGeer P. L. (1993) Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. Am. J. Pathol. 142, 1574-1585.
27. Kermode A. G., Thompson A. J., Tofs P., MacManus D. G., Kendall B. E., Kingsley D. P. E., Moseley I. F., Rudge P., and McDonald W. I. (1990) Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenic and clinical implications. Brain 113, 1477-1489.
28. Lee E. K., Kehrli M. E. Jr., Dietz A. B., Bosworth B. T., and Reinhardt T. A. (1996) Cloning and sequencing of a cDNA encoding bovine intercellular adhesion molecule 3 (ICAM-3). Gene 174, 311-313.
29. Leveugle B., Mazurier J., Legrand D., Mazurier C., Montreuil J., and Spik G. (1993) Lactotransferrin binding to its platelet receptor inhibits platelet aggregation. Eur. J. Biochem. 213, 1205-1211.
30. Leveugle B., Spik G., Perl D. P., Bouras C., Fillit H. M., and Hof P. R. (1994) The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Res. 650, 20-31.
31. Leveugle B., Faucheux B. A., Bouras C., Nillesse N., Spik G., Hirsch E. C., Agid Y., and Hof P. R. (1996) Immunohistochemical analysis of the iron-binding protein lactotransferrin in Parkinson's disease. Acta Neuropathol. 91, 566-572.
32. Machnicki M., Zimecki M., and Zagulski T. (1993) Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int. J. Exp. Pathol. 74, 433-439.
33. Masson P. L. (1970) La lactoferrine, protéine des sécrétions externes et des leucocytes neutrophiles, in Médico-Monographies d'agrégés (Masson P. L., ed). pp. 93-165. Arscia, Bruxelles.
34. Masson P. L., Heremans J. F., and Schönne E. (1969) Lactoferrin: an iron binding protein in neutrophilic leukocytes. J. Exp. Med. 130, 643-658.
35. Mattsby-Baltzer I., Roseanu A., Motas C., Elverfors J., Engberg I., and Hanson L. A. (1996) Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human monocytic cells. Pediatr. Res. 40, 257-262.
36. McCarron R. M., Wang L., Racke M. K., McFarlin D. E., and Spatz M. (1993) Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J. Neuroimmunol. 43, 23-30.
37. McGeer E. G. and McGeer P. L. (1998) The importance of inflammatory mechanisms in Alzheimer disease. Exp. Gerontol. 33, 371-378.
38. McGeer P. L. and McGeer E. G. (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21, 195-218.
39. Mecocci P., Parnetti L., Reboldi G. P., Santucci C., Gaiti A., Ferri C., Gemini I., Romagnoli M., Cadini D., and Senin U. (1991) Blood-brain barrier in a geriatic population: barrier function in degenerative and vascular dementias. Acta Neurol. Scand. 84, 210-213.
40. Méresse S., Dehouck M.-P., Delorme P., Bensaïd M., Tauber J. P., Delbart C., Fruchart J. C., and Cecchelli R. (1989) Bovine brain capillary endothelial cells express tight junctions and monoamine oxidase activity in long-term culture. J. Neurochem. 53, 1363-1371.
41. Mogi M., Harad M., Riederer P., Narabayashi H., Fujita K., and Nagatsu T. (1994) Tumor necrosis factor a increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci. Lett. 165, 208-210.
42. Montreuil J., Tonnelat J., and Mullet S. (1960) Préparation et propriétés de la lactosidérophiline (lactotransferrine) du lait de femme. Biochim. Biophys. Acta 45, 413-421.
43. Nguyen M., Strubel N. A., and Bischoff J. (1993) A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 365, 267-269.
44. Nuijens J. H., van Berkel P. H. C., and Schanbacher F. L. (1996) Structure and biological actions of lactoferrin. J. Mamm. Gland Biot. Neoplas. 1, 285-295.
45. Olofsson T., Olsson I., and Venge P. (1977) Myeloperoxidase and lactoferrin of blood neutrophils and plasma in chronic granulocytic leukemia. Scand. J. Haematol. 18, 113-120.
46. Osmand A. P. and Switzer R. C. III (1991) Differential distribution of lactoferrin and Alz-50 immunoreactivities in neuritic plaques and neurofibrillary tangles in Alzheimer's disease, in Alzheimer's Disease: Basic Mechanisms, Diagnosis and Therapeutic Strategies (Iqbal K., McLachlan D. R. C., Winblad B., and Wisniewski H. M., eds), pp. 219-228. Wiley, New York.
47. Pober J. S. (1998) Activation and injury of endothelial cells by cytokines. Pathol. Biol. 46, 159-163.
48. Sambrook J., Fritsch E. F., and Maniatis T., eds (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
49. Sawada M., Kondo N., Suzumura A., and Marunouchi T. (1989) Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 491, 394-397.
50. Schubert P., Ogata T., Miyazaki H., Marchini C., Ferroni S., and Rudolphi K. (1998) Pathological immuno-reactions of glial cells in Alzheimer's disease and possible sites of interference. J. Neural Transm. [Suppl.] 54, 167-174.
51. Sharief M. K. and Thompson E. J. (1992) In vivo relationship of tumor necrosis factor-α to blood-brain barrier damage in patients with active multiple sclerosis. J. Neuroimmunol. 38, 27-34.
52. Sharif S. F., Hariri R. J., Chang V. A., Barie P. S., Wang R. S., and Ghajar J. B. (1993) Human astrocyte production of tumor necrosis factor-alpha, interleukin-1 beta and interleukin-6 following exposure to lipopolysaccharide endotoxin. Neural Res. 15, 109-112.
53. Siebert P. D. and Huang B. C. B. (1997) Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines. Proc. Natl. Acad. Sci. USA 94, 2198-2203.
54. Terent A., Hallgren R., Venge P., and Bergstrom K. (1981) Lactoferrin, lysozyme, and beta 2-microglobulin in cerebrospinal fluid. Elevated levels in patients with acute cerebrovascular lesions as indices of inflammation. Stroke 12, 40-46.
55. Tokunaga K., Nakamura Y., Sakata K., Fujimori K., Ohkubo M., Sawada K., and Sakiyama S. (1987) Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res. 47, 5616-5619.
56. Wong D. (1992) Upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in primary cultures of human brain microvessel endothelial cells by cytokines and lipopolysaccharide. J. Neuroimmunol. 39, 11-21.
57. Yamabe T., Dhir G., Cowan E. P., Wolf A. L., Bergey G. K., Krumholz A., Barry E., Hoffman P. M., and Dhib-Jalbut S. (1994) Cytokinegene expression in measles-infected adult human glial cells. J. Neuroimmunol. 49, 171-179.
58. Zagulski T., Lipinski P., Zagulska A., Broniek S., and Jarzabek Z. (1989) Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br. J. Exp. Pathol. 70, 697-704.